Source:http://linkedlifedata.com/resource/pubmed/id/15808570
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-4-5
|
pubmed:abstractText |
This study including prevention and rescue experiments was performed to examine the efficacy of FK778 and its interactions with FK506. In the prevention experiment, Brown-Norway rats transplanted with a 7 Lewis livers received day-course of FK778 or a combination of FK778 and FK506 treatment. For the rescue experiment, the recipients were additionally treated with FK778 from days 7 to 13. Blood chemistry and histopathological findings were used to examine the host and the graft condition. Donor-specific IgM was measured using enzyme-linked immunosorbent assays. The serum trough level of FK778 was examined by high-performance liquid chromatography. FK778 suppressed acute rejection in a dose-dependent manner. The optimal FK778 dosage was 20 mg/kg body weight (BW) d. FK778 treatment from days 7 to 13 rescued liver grafts from ongoing rejection. The combination of FK506 (0.125 mg/kg BW/d) and FK778 (20 mg/kg BW/d) maintained better graft condition than FK778 (20 mg/kg BW/d) monotherapy. In conclusion, FK778 prevents acute rejection in and rescues transplant recipients from ongoing rejection after rat liver transplantation. The optimal monotherapy dosage of FK778 was 20 mg/kg BW/d. Combination therapy with FK506 was more beneficial than FK778 monotherapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-cyano-3-hydroxy-N-(4-(trifluoromet...,
http://linkedlifedata.com/resource/pubmed/chemical/Alkynes,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Isoxazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0041-1345
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
126-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15808570-Alkynes,
pubmed-meshheading:15808570-Animals,
pubmed-meshheading:15808570-Antibody Formation,
pubmed-meshheading:15808570-B-Lymphocytes,
pubmed-meshheading:15808570-Graft Rejection,
pubmed-meshheading:15808570-Immunity, Cellular,
pubmed-meshheading:15808570-Immunosuppressive Agents,
pubmed-meshheading:15808570-Isoxazoles,
pubmed-meshheading:15808570-Liver Transplantation,
pubmed-meshheading:15808570-Male,
pubmed-meshheading:15808570-Nitriles,
pubmed-meshheading:15808570-Rats,
pubmed-meshheading:15808570-Rats, Inbred BN,
pubmed-meshheading:15808570-Rats, Inbred Lew,
pubmed-meshheading:15808570-T-Lymphocytes,
pubmed-meshheading:15808570-Tacrolimus,
pubmed-meshheading:15808570-Transplantation, Homologous
|
pubmed:articleTitle |
FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
|
pubmed:affiliation |
Department of Surgery, Osaka City University Graduate School of Medicine, Japan. m7577175@msic.med.osaka-cu.ac.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study
|